Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer
Open Access
- 1 November 1993
- Vol. 72 (9), 2638-2643
- https://doi.org/10.1002/1097-0142(19931101)72:9<2638::aid-cncr2820720919>3.0.co;2-n
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Serum prostate-specific antigen: the most useful tumor marker.Journal of Clinical Oncology, 1992
- Prostate cancer: retrograde urethrography to improve treatment planning for radiation therapy.Radiology, 1991
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Therapeutic options in the management of incidental carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Conformal static field therapy for low volume low grade prostate cancer with rigid immobilizationInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Full integration of the beam's eye view concept into computerized treatment planningInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989